Nalu Medical PNS System Acquired by BSCI
Boston Sci acquisition expected to expand the neuromodulation offerings for people living with chronic pain.
Tag Archives: Boston Scientific
Boston Scientific Launches Head-to-Head AGENT DCB vs. Standard of Care Trial
The company initiated trials for AGENT DCB, a drug-coated coronary balloon approved for use in the U.S. and currently indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease.
Boston Scientific Vascular Stent Recall: Carotid WALLSTENT Monorail Endoprosthesis
The FDA is aware that Boston Scientific is recalling he Carotid WALLSTENT Monorail Endoprosthesis due to a manufacturing defect that created an inner lumen smaller than specifications, causing resistance when withdrawing the stent delivery system.
Boston Sci receives FDA approval for expanded labeling of FARAPULSE™
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation.
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, furthering company’s strategy to address coronary and peripheral disease.
Perseverance Is Key
Maria Shepherd, president and founder of Medi-Vantage and co-founder of MedExecWomen, discusses her career in the medical device industry, what led her to launch her own company and the joy of “finding her tribe” among fellow female executives committed to bringing up the next generation of women leaders in MedTech.
Boston Scientific To Purchase Majority Stake of M.I.Tech
“M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.”
Boston Scientific to Acquire Baylis Medical for $1.75 Billion
The deal will boost Boston Scientific’s electrophysiology and structural heart product portfolios.
Boston Scientific Recalls Venous Stent System Due Device Migration
Nearly 32,000 stent systems have been recalled in the United States.
Boston Scientific Settles Surgical Mesh Claims for Nearly $189 Million
The company was accused of hiding serious health risks related to implantation of its transvaginal surgical mesh products.